|
Net income
|
|
$20.2m
|
$19.7m
|
$37.0m
|
$32.2m
|
$30.4m
|
|
Depreciation and amortization
|
|
$18.5m
|
$17.2m
|
$15.8m
|
$15.0m
|
$14.6m
|
|
Deferred income taxes
|
|
$6.0m
|
$433k
|
($10.8m)
|
$674k
|
$1.4m
|
|
Stock-based compensation
|
|
$19.1m
|
$7.8m
|
$14.0m
|
$3.8m
|
$7.1m
|
|
Assets write-down
|
|
—
|
$0
|
$1.1m
|
$1.1m
|
$34k
|
|
Inventory write-off and obsolescence
|
|
—
|
($142k)
|
$1.7m
|
$2.9m
|
$2.3m
|
|
Net provision for credit losses
|
|
($256k)
|
($6k)
|
$179k
|
$1.2m
|
$3.4m
|
|
Changes in value of life insurance policies
|
|
($2.7m)
|
$5.1m
|
($5.0m)
|
($2.8m)
|
($1.9m)
|
|
Realization of pension obligation
|
|
($234k)
|
$451k
|
($892k)
|
($33k)
|
$337k
|
|
Other non-cash items
|
|
($2.5m)
|
($547k)
|
$3.3m
|
($1.0m)
|
$682k
|
|
Accounts receivable
|
|
($13.5m)
|
($10.1m)
|
($2.6m)
|
($3.6m)
|
($5.0m)
|
|
Inventories
|
|
($4.5m)
|
($14.9m)
|
($13.0m)
|
$9.4m
|
$2.6m
|
|
Prepaid expenses and other current assets
|
|
$1.8m
|
($76k)
|
$2.0m
|
($5.7m)
|
($1.2m)
|
|
Other assets
|
|
($523k)
|
($1.4m)
|
$1.5m
|
($289k)
|
$28k
|
|
Accounts payable
|
|
$6.6m
|
$15.4m
|
($12.9m)
|
$519k
|
$477k
|
|
Accrued expenses
|
|
($8.8m)
|
($1.3m)
|
($375k)
|
$2.5m
|
($2.7m)
|
|
Unearned revenues
|
|
$2.3m
|
($1.8m)
|
($1.2m)
|
$4.6m
|
($3.8m)
|
|
Other liabilities
|
|
($3.9m)
|
($10.9m)
|
($2.2m)
|
$460k
|
($5.1m)
|
|
Proceeds from insurance recovery - Aberdeen facility
|
|
$726k
|
$583k
|
$0
|
$2.1m
|
$10.0m
|
|
Proceeds from sale of assets
|
|
$678k
|
$1.9m
|
$485k
|
$1.7m
|
$3.0m
|
|
Patents and other intangibles
|
|
($318k)
|
($29k)
|
$67k
|
$20k
|
($150k)
|
|
Acquisitions, net of cash acquired
|
|
—
|
—
|
$0
|
$0
|
($1.2m)
|
|
Net proceeds on life insurance policies
|
|
$1.4m
|
$3.7m
|
$3.4m
|
$2.8m
|
$778k
|
|
Equity related transaction costs
|
|
($861k)
|
($411k)
|
($4.1m)
|
($756k)
|
$0
|
|
Cash payments for interest
|
|
$10.5m
|
$9.3m
|
$11.2m
|
$10.9m
|
$8.2m
|
|
Cash payments for income taxes
|
|
$9.1m
|
$14.1m
|
$16.0m
|
$17.6m
|
$18.7m
|
|
Restricted shares withheld from employees for settlement of tax liabilities
|
|
—
|
—
|
$0
|
$0
|
$3.1m
|
|
Business acquisition contingent cash consideration
|
|
—
|
—
|
$0
|
$0
|
$4.1m
|
|
Equity related transaction costs incurred but not paid for as of the end of the year
|
|
$0
|
$0
|
$756k
|
$0
|
$0
|
|
Net cash provided by operating activities
|
|
$36.6m
|
$25.0m
|
$24.8m
|
$56.4m
|
$37.0m
|
|
Insurance recovery on property, plant and equipment
|
|
—
|
$0
|
$0
|
($4.4m)
|
($6.8m)
|
|
Capital expenditures - operations
|
|
($13.5m)
|
($10.2m)
|
($10.6m)
|
($13.0m)
|
($11.2m)
|
|
Capital expenditures - rebuilding of Aberdeen facility
|
|
—
|
—
|
$0
|
($1.1m)
|
($3.4m)
|
|
Capital expenditures incurred but not paid for as of the end of the year
|
|
$1.4m
|
$1.2m
|
$963k
|
$1.7m
|
$1.5m
|
|
Net cash used in investing activities
|
|
($10.2m)
|
($3.9m)
|
($6.7m)
|
($6.4m)
|
($2.2m)
|
|
Proceeds from long-term debt
|
|
$155.0m
|
$116.0m
|
$202.0m
|
$44.0m
|
$48.0m
|
|
Debt issuance costs
|
|
$0
|
($2.2m)
|
($1.3m)
|
($19k)
|
($1.7m)
|
|
Repayment of long-term debt
|
|
($226.0m)
|
($131.0m)
|
($211.0m)
|
($82.0m)
|
($63.0m)
|
|
Repurchase of common stock
|
|
($8.3m)
|
($3.9m)
|
($2.2m)
|
($5.3m)
|
($12.4m)
|
|
Dividends paid
|
|
($1.8m)
|
($1.9m)
|
($1.9m)
|
($1.9m)
|
($1.9m)
|
|
Other financing activities
|
|
($508k)
|
($2k)
|
($54k)
|
$0
|
($254k)
|
|
Net cash used in financing activities
|
|
($22.5m)
|
($23.4m)
|
($18.4m)
|
($46.0m)
|
($31.3m)
|
|
NET CHANGE IN CASH AND CASH EQUIVALENTS
|
|
$3.9m
|
($2.3m)
|
($308k)
|
$4.0m
|
$3.5m
|
|
CASH AND CASH EQUIVALENTS, beginning of year
|
|
$17.7m
|
$15.4m
|
$15.1m
|
$19.2m
|
$22.7m
|